SIM2s was also reported to be an aggressive prostate cancer biomarker since SIM2s protein was associated with increased preoperative serum prostate specific antigen (PSA), high histological grade, invasive tumor growth and increased tumor cell proliferation [13]. The gene discussed is KLK3; the disease is neoplasm.